Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cocrystal Pharma Inc COCP

Healthcare
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function... see more

Recent & Breaking News (NDAQ:COCP)

CLASS ACTION UPDATE for AMPE, COCP, ABBV and SKX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire September 21, 2018

COCRYSTAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Cocrystal Pharma, Inc. To Contact The Firm

PR Newswire September 21, 2018

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Cocrystal Pharma, Inc., formerly known as BioZone Pharmaceuticals, Inc.

Business Wire September 21, 2018

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Skechers USA, Inc. (SKX) and Lead Plaintiff Deadline – November 5, 2018

GlobeNewswire September 21, 2018

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Cocrystal Pharma, Inc. (COCP) (formerly BioZone Pharmaceuticals, Inc. (BZNE)) and Encourages COCP Investors to Contact the Firm

GlobeNewswire September 20, 2018

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. – COCP (formerly known as BioZone Pharmaceuticals, Inc. - BZNE)

Business Wire September 20, 2018

Cocrystal Pharma Completes Patient Enrollment in Phase 2a Study Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C

GlobeNewswire September 20, 2018

Bragar Eagel & Squire, P.C. is Investigating Cocrystal Pharma, Inc. (COCP) (formerly BioZone Pharmaceuticals, Inc. (BZNE)) on Behalf of Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire September 17, 2018

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intrexon Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire September 14, 2018

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Intrexon Corporation – XON

Business Wire September 14, 2018

Cocrystal Pharma Reports 2018 Second Quarter Financial Results and Provides Corporate Update

GlobeNewswire August 9, 2018

Cocrystal Pharma Commences Enrollment and Initiates Patient Dosing in Phase 2a Study Evaluating CC-31244 for the Treatment of HCV

GlobeNewswire June 28, 2018

Cocrystal Pharma Announces Inclusion in Russell Microcap® Index

GlobeNewswire June 25, 2018

Cocrystal Pharma Announces Nasdaq Closing Bell Ceremony

GlobeNewswire June 4, 2018

Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update

GlobeNewswire May 11, 2018

Cocrystal Pharma to Present at the Fred Hutch and Merck Infectious Disease Summit

GlobeNewswire May 10, 2018

COCRYSTAL PHARMA, INC., PRICES $8,000,000 COMMON STOCK OFFERING

GlobeNewswire May 1, 2018

Benzinga's Daily Biotech Pulse: Intra-cellular Moves On Poster Presentation, Earnings Beats From Vertex, Exact Sciences

Benzinga.com  April 27, 2018

Cocrystal Pharma Announces Uplist to The Nasdaq Capital Market

GlobeNewswire March 12, 2018

Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update

GlobeNewswire November 8, 2017